Posted by Michael Wonder on 15 Mar 2018
Decision to open list montelukast tablets
15 March 2018 - PHARMAC will remove the Special Authority and Hospital Medicine restrictions on montelukast 4 mg, 5 mg & 10 mg tablets and to apply the dispense all-at-once (stat dispensing) rule from 1 April 2018.
Montelukast tablets are currently funded for the treatment of pre-school wheeze, exercise induced asthma, and aspirin desensitisation.
This decision widens access to funded montelukast tablets from 1 April 2018 by removing the current Special Authority and restrictions.
